Patient-friendly peptide education
General peptide therapy, clinics, safety, brands and long-tail topics.
Recently published
Dimension, a young venture capital firm at the vanguard of biotechnology’s embrace of artificial intelligence, has closed its biggest fund to date. The firm on Tuesday announced it raised $800 million for “Dim…
Read guide →When drug developers go after the same disease, clinical trial results often have a see-saw effect on the stock market. Investors inevitably view one company’s data as stronger than its rivals, and share price…
Read guide →Beeline Medicines has attracted another $126.3 million in funding, the company said Tuesday , adding to an enormous Series A round originally announced in the spring to fund its work on drugs for immune condit…
Read guide →Arctic Berry Peptide Eminence What I Learned from Formulating Arctic Berry Peptide Eminence Over the Years Successive waves of technological advancement have, over time, transformed peptide synthesis from a sp…
Read guide →Scribe Therapeutics, a biotechnology startup developing genetic medicines for cardiometabolic disorders, has revealed plans to chase an initial public offering. In a filing with the Securities and Exchange Com…
Read guide →Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback . Dive Brief: Royalty management company Zymeworks is buying Theravance Biopharma, announcing Monday a $929 mil…
Read guide →The Food and Drug Administration approved Friday Viridian Therapeutics’ treatment Lumvoa for thyroid eye disease, setting up a showdown between Amgen’s blockbuster medicine Tepezza and the drug analysts believ…
Read guide →Today, a brief rundown of news from Lyell Immunopharma and Biogen as well as updates from the European Life Sciences Coalition and Novocure that you may have missed. Lyell Immunopharma said Thursday it has beg…
Read guide →Atlanta biotechnology company Altesa BioSciences announced Thursday it closed a $75 million Series B round to advance a drug it sees as helpful treating multiple chronic lung conditions. Altesa’s drug vapendav…
Read guide →Korsana Biosciences, a biotechnology company making a treatment for Alzheimer’s disease, officially emerged from stealth Wednesday with $175 million to round out its portfolio of drugs for neurodegenerative co…
Read guide →Dive Brief: Shares for Vir Biotechnology climbed by nearly 30% Tuesday after the company reported positive early data as well as a partnership involving an experimental drug it’s developing for prostate cancer…
Read guide →Dive Brief: Ipsen plans to buy Memo Therapeutics to expand its rare disease pipeline, adding an experimental medicine poised to start a pivotal trial this year. Investors in Switzerland-based Memo will receive…
Read guide →Dive Brief: Drug developers making new medicines to treat autoimmune conditions and cancer made up more than 40% of the venture funding rounds in the first half of 2026, BioPharma Dive data show . Of the more …
Read guide →Celea Therapeutics, a biotechnology startup testing a next-generation treatment for idiopathic pulmonary fibrosis, said in a Thursday announcement it has brought in $180 million to continue its work. Launched …
Read guide →Vertex Pharmaceuticals is making the largest acquisition bet in its history, announcing late Monday an agreement to purchase a biotechnology company, Crinetics Pharmaceuticals, that recently brought to market …
Read guide →Biotechnology venture capital funding continued a multi-year surge in the first half of 2026, as strong public market performance and a spike in dealmaking activity helped spur interest in privately held drug …
Read guide →Today, a brief rundown of news involving Johnson & Johnson and AstraZeneca, as well as updates from Spero Therapeutics, Chai Discovery, AdvanCell and Summit Therapeutics that you may have missed. Shares of Joh…
Read guide →Peptide Vite Glp Understanding Structure‑Activity Relationships Within Peptide Vite Glp Growing consumer awareness of peptide biochemistry has reshaped how cosmetic formulations are evaluated by educated shopp…
Read guide →Flagship Pioneering has launched a new biotechnology firm that believes it’s found a way to solve the problems that have long held back genetic medicine. Called Serif Biomedicines, the startup officially debut…
Read guide →Today, a brief rundown of news from Eli Lilly and the Food and Drug Administration, as well as updates from Regeneron, Amgen, BridgeBio Oncology Therapeutics and Novo Nordisk that you may have missed. Eli Lill…
Read guide →Browse by subject
Each topic opens a crawlable collection of related articles and resources.